CUREXO Technology Corporation has announced that Brent D. Mittelstadt, a pioneer in surgical robotics, will take the reins as President and Chief Executive Officer. Mittelstadt holds eight patents and has published extensively in the field of computer-assisted orthopedic surgery.
Twenty-three years ago Mittelstadt began spending his laboratory time in surgical robotics as a visiting research scientist at the IBM T.J. Watson Research Center. He is responsible for much of the early development of CT-guided robotic systems for joint replacement surgery. In 1990, with an initial investment from IBM, Mittelstadt cofounded Integrated Surgical Systems (ISS) to develop a surgical robot system to assist with hip and knee replacement surgery. In 2007, ISS transferred all of its assets to CUREXO Technology Corporation.
While at ISS, Mittelstadt served as Director of Surgical Applications, where he led the development and refinement of both the early pin based hip application, as well as the DigiMatch ROBODOC Surgical System for Total Hip Arthroplasty (THA), which received FDA clearance in August 2008. Following this position, Mittelstadt signed on at Consensus Orthopedics (formerly Hayes Medical Inc.), where he was Director of Marketing. Mittelstadt was part of a turnaround management team that was integral in transforming the company. When he first jointed Consensus, it was suffering from declining sales and a poor reputation in the market. Today, Consensus Orthopedics is achieving over 60% annual growth in revenue. While there, Mittelstadt was involved in the development of new implants and line extensions as well as re- designing the total knee instrumentation system to address changes in the joint replacement market.